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Abstract
Background:  The chlamydiae alter many aspects of host cell biology, including the division
process, but the molecular biology of these alterations remains poorly characterized. Chlamydial
inclusion membrane proteins (Incs) are likely candidates for direct interactions with host cell
cytosolic proteins, as they are secreted to the inclusion membrane and exposed to the cytosol. The
inc gene CT223 is one of a sequential set of orfs that encode or are predicted to encode Inc
proteins. CT223p is localized to the inclusion membrane in all tested C. trachomatis serovars.
Results: A plasmid transfection approach was used to examine the function of the product of
CT223 and other Inc proteins within uninfected mammalian cells. Fluorescence microscopy was
used to demonstrate that CT223, and, to a lesser extent, adjacent inc genes, are capable of blocking
host cell cytokinesis and facilitating centromere supranumeracy defects seen by others in
chlamydiae-infected cells. Both phenotypes were associated with transfection of plasmids encoding
the carboxy-terminal tail of CT223p, a region of the protein that is likely exposed to the cytosol in
infected cells.
Conclusion: These studies suggest that certain Inc proteins block cytokinesis in C. trachomatis-
infected cells. These results are consistent with the work of others showing chlamydial inhibition
of host cell cytokinesis.
Background
Chlamydiae are obligate intracellular bacteria that repli-
cate in a cytoplasmic vacuole (the inclusion) within host
cells [1,2]. All Chlamydia spp. are significant pathogens,
and infections occur in a wide variety of animal species.
Chlamydia trachomatis infections lead to serious mucosal
diseases of humans including blinding trachoma [3] and
diseases of the genital tract [4]. The study of chlamydial
host-pathogen relationships is complicated by the lack of
a genetic system to manipulate the chlamydial genome,
and thus, alternate approaches must be used to under-
stand chlamydial virulence properties. One approach that
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has been particularly useful in these studies is the use of
surrogate genetic systems including yeast, mammalian
cells, and other bacterial species [5-10].
Inhibition of the host cell cycle by chlamydiae was dem-
onstrated by early researchers [11,12] and was expanded
upon recently by Greene and Zhong [13]. Other recent
investigations have demonstrated that chlamydial infec-
tion alters the cell cycle in a variety of ways, leading to cen-
trosomal defects [14] and slowing of host cell division
[15]. The molecular mechanisms leading to these changes
are poorly understood. Recent studies have suggested a
possible role of chlamydiae in cancers of different infected
tissues [16-18] and, thus, the role of chlamydiae in altera-
tions of cell cycle biology are of significance.
The different chlamydial species each produce a set of pro-
teins, termed Incs, that are localized to the chlamydial
inclusion membrane and exposed to the cytosol of the
host cell [19]. Each sequenced chlamydial genome
encodes over 40 candidate Incs, and there are both con-
served and species-specific Incs among the different
chlamydiae. The demonstrated function of a limited
number of Inc proteins is known [9,20-23], but most are
poorly characterized.
Chlamydia trachomatis encodes a species-specific set of Incs
within orfs CT223-CT229.  CT224  and  CT225  have no
clear homologs in any other chlamydiae, while CT223,
and CT226–CT229 have homologs only in C. muridarum,
a closely related chlamydial species [24]. The localization
to the inclusion membrane of the products of CT223,
CT225, CT226, and CT229 was confirmed via fluorescence
microscopy [25]. Transcription of CT228 and CT229 is
initiated very early following infection of cells [26] and,
therefore, the encoded proteins are hypothesized to be
essential to early inclusion development. Recent work by
Rzomp et al. demonstrated that CT229p associated with
Rab4 in a two-hybrid assay and in mammalian cells [20],
but the function of any of the proteins encoded by the
other orfs in this group is not known. To address possible
functions of candidate C. trachomatis Incs, we used a plas-
mid transfection system to introduce genes encoding dif-
ferent Incs into mammalian cells, and then characterized
any resulting phenotypes with fluorescence microscopy.
These investigations demonstrated that transfection with
plasmids expressing CT223, and to a lesser extent, CT224
and CT225, led to a block in host cell cytokinesis. Cells
transfected with plasmids encoding CT223p led to an
inhibition of cytokinesis that was similar to that seen in C.
trachomatis-infected cells. The block was shown to be asso-
ciated with the carboxy-terminal end of CT223p, the
region of the protein hypothesized to be exposed to the
host cell cytosol at the surface of the inclusion. Alleles of
CT223 from different strains yielded similar inhibition of
cytokinesis, consistent with the inhibitory effect on cyto-
kinesis by all tested C. trachomatis serovars [13].
Methods
Chlamydial strains, DNA preparation, and host cell lines
Elementary bodies (EB) of Chlamydia trachomatis strains
D/UW3, J/UW36, J9235, J(s)1980, J(s)6686 and LGV-
434, C. caviae strain GPIC, and C. muridarum strain Nigg
were used in infections and/or for preparation of genomic
DNA samples that were used as PCR templates. Genomic
DNA was prepared by boiling EB suspensions in a water
bath for 10 minutes followed by removal of bacterial
debris via centrifugation. HeLa or McCoy cells (ATCC)
were cultured in Minimal Essential Medium supple-
mented with 10% fetal bovine serum and 10 μg/ml gen-
tamicin and grown at 37°C in 5% CO2.
Construction of plasmids and oligonucleotides used in 
transfection experiments
Chlamydial open reading frame (orf) designations will be
in italics and will reflect their numerical assignment in the
C. trachomatis genome sequence presented by Stephens et
al. [27]. The single C. muridarum orf tested (TC0495) was
as predicted using the sequence of Read et al. [28]. The
encoded chlamydial protein will be shown in regular text
and will be followed by a "p". The plasmid pcDNA4/His-
MaxC (Invitrogen) was used for cloning and expression of
intact or truncated coding regions of C. trachomatis CT223,
CT224, CT225, CT226, CT227, CT228, CT229, incA, incC,
C. caviae incA, incB, incC, and Aequorea victoria gfp genes.
Plasmids were constructed that encoded the carboxy ter-
minal 179 and 56 amino acids of CT223p (CT223/179p
and CT223/56p, respectively), and the amino acids
between positions 91 and 214 of CT223p (CT223/91p).
pcDNA4/HisMaxC encodes a polyhistidine tag that was
fused to the amino terminus of each recombinant
polypeptide tested. Oligonucleotides were designed to
include appropriate restriction sites for cloning (Table 1).
PCR reactions were carried out using Pfx polymerase and
chlamydial genomic DNA as template, and the entire cod-
ing sequence as predicted from the serovar D genome
sequence was used to define the orfs. All constructs were
confirmed by nucleotide sequence analysis.
Antibodies, transfection experiments and 
immunofluorescence microscopy
Monoclonal antibody recognizing chlamydial lipopoly-
saccharide was a gift from Harlan Caldwell of the Rocky
Mountain laboratories, Hamilton, MT. Monoclonal anti-
body A57B9 (anti-HSP60) recognizes a genus common
epitope on chlamydial HSP60 protein [25]. Monoclonal
antibodies used in the analysis of CT223p localization in
C. trachomatis-infected HeLa or McCoy cells were pro-BMC Microbiology 2009, 9:2 http://www.biomedcentral.com/1471-2180/9/2
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duced and used as previously described [25]. Rabbit poly-
clonal anti-CT223p antisera was generated against the
peptide sequence NH3-NGINDLSPAPEAKKTGSGL and
were produced commercially (Proteintech, Chicago, IL).
For these experiments, cells were infected with chlamy-
diae and incubated for time periods indicated in the figure
legends. Cells were then fixed with 100% methanol and
used for immunofluorescence.
Transfection of plasmids into HeLa or McCoy cells grown
on sterile glass coverslips was conducted using Lipo-
fectamine 2000 (Gibco) according to the manufacturer's
instructions. Transfected cells were incubated for 36 hours
and then fixed with methanol. The efficiency of transfec-
tion was determined by labeling with monoclonal anti-6-
His antibody (Clontech) and secondary FITC or TRITC
fluorescent antibodies (Southern Biotechnology Associ-
ates) to detect the product of the transgene. Monoclonal
anti-γ-tubulin antibodies (Sigma) were used to detect cen-
trosomes. Cells expressing gfp  were analyzed without
labeling. Coverslips were examined under 1000× magnifi-
cation using a Leica fluorescence microscope and images
were collected using the SPOT digital camera system
(Diagnostic Instruments Inc., Sterling Heights, MI). The
rates of cells with a polynuclear phenotype were deter-
mined by counting transfected cells with two or more
nuclei among the total population of transfected cells.
Statistical analysis
The number of transfected cells having a polynuclear phe-
notype was evaluated in at least three independent exper-
iments for each plasmid construct tested. A total of at least
500 individual transfected cells were counted for each
tested plasmid construct. Standard deviations were calcu-
lated for each individual plasmid construct examined and
the significance of differences between means was evalu-
ated using both the Student's t-test and the Kruskall-Wal-
lis test, as calculated using the Instat software program
(GraphPad Software, San Diego, CA).
Results
Examination of the association between infection and a 
reduced rate of cytokinesis
The block in cytokinesis identified by Greene and Zhong
[13] was tested using laboratory prototype strains (LGV-
434 and D/UW3) and a recent clinical isolate {J(s)6686}.
Table 1: Oligonucleotides used for amplification of inc genes by PCR.
Name/Site Sequence Target Gene
DA71 EcoRI agcaGAATTCttgagatctagaaaagaagc CT223 C. trachomatis
DA97 KpnI agcaGGTACCaatggtgagtttagcagg CT223 C. trachomatis
DA116 EcoRV agcaGATATCctacacccgagagccattg CT223 C. trachomatis
DA119 EcoRV agcaGATATCctaattagccgttttcagatt CT223/179 C. trachomatis
DA121 EcoRV agcaGATATCctactcttctatctgctcttt CT223/91 C. trachomatis
DA122 EcoRI agcaGAATTCatggagcttaaagctttagag CT223/56 C. trachomatis
DA76 BamHI agcaGGATCCttattttttacgacgtgc CT229 C. trachomatis
DA99 KpnI agcaGGTACCaatgagctgttctaataa CT229 C. trachomatis
DA98 BamHI agcaGGATCCatgagtactactattgg CT228 C. trachomatis
DA74 PstI agcaCTGCAGctaagaagcttggttgtc CT228 C. trachomatis
DA 131 EcoRI agcaGAATTCatgtcttatcttttttcc CT227 C. trachomatis
DA 132 EcoRV agcaGATATCtcatgagacacttatcac CT227 C. trachomatis
DA 129 EcoRI agcaGAATTCatgttggccttttttcga CT226 C. trachomatis
DA130 EcoRV agcaGATATCttatatcagactttccaa CT226 C. trachomatis
DA127 EcoRI agcaGAATTCatggtggctaacaactttatt CT225 C. trachomatis
DA128 EcoRV agcaGATATCttaatcccacccatgttt CT225 C. trachomatis
DA125 EcoRI agcaGAATTCatgagttttgttggaagt CT224 C. trachomatis
DA126 Xhol agcaCTCGAGctaatcattgggaaatga CT224 C. trachomatis
DA34 EcoRI agcaGAATTCatgacaacgcctactact incA C. trachomatis
DA21 EcoRV agcaGATATCctaggagctttttgtggg incA C. trachomatis
DA22 EcoRI agcaGAATTCggcaacgttatgacgtc incC C. trachomatis
DA23 EcoRV agcaGATATCttagcttacatatatttg incC C. trachomatis
JL003 EcoRI agcaGAATTCatgacagtatccacaaa incA C. caviae
JL010 EcoRV agcaGATATCacttaactatctttatc incA C. caviae
JL007 EcoRI agcaGAATTCatgtcaacaacaccatc incB C. caviae
JL006 EcoRV agcaGATATCttaagattctgtttgat incB C. caviae
JL014 EcoRI agcaGAATTCatgacctctgtaagaga incC C. caviae
JL013 EcoRV agcaGATATCtaaatgtccggtaggag incC C. caviae
DA114 EcoRI agcaGAATTCatggtgagcaagggcga GFP
DA115 EcoRV agcaGATATCctacttgtacagctccatg GFP
The restriction sites built into oligonucleotides for cloning purposes are shown in capital letters.BMC Microbiology 2009, 9:2 http://www.biomedcentral.com/1471-2180/9/2
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In experiments with multiplicities of infection of approx-
imately 3, an increase in the polynuclear phenotype was
verified both qualitatively (Fig. 1A) and quantitatively
(Fig. 1B). These results are consistent with their data using
laboratory strains and confirm that C. trachomatis infec-
tion blocks or slows cytokinesis in infected cells.
Distribution of CT223p at the inclusion membrane varies 
in different C. trachomatis strains
CT223p is localized to the inclusion membrane in cells
infected by C. trachomatis at time points after 8 hours post
infection (p.i.). Consistent with our previous work [25],
patches of CT223p protein are readily detectable at time
points 12 h p.i. and later (Fig. 2A–D). The localization of
CT223p is different in cells infected by representatives of
different C. trachomatis serovars. In cells fixed at early and
middle time points p.i., the labeling in cells infected by dif-
ferent serovars is similar and is manifested as dash-like or
patchy localization of protein at the inclusion surface (Fig.
2A, C). At late time points however, a difference becomes
apparent, as the labeling CT223p of a serovar J isolate (Fig.
2D) becomes more diffuse than in isolates of serovar L2
(Fig. 2B) and serovar D (not shown). These differences in
labeling are independent of cell type (either McCoy or
HeLa) or fixative (paraformaldehyde or methanol).
We have shown that CT223p in certain strains – including
J(s)1980 and J(s)6686 – is not recognized in fluorescent
microscopic analysis using two different anti-CT223p
monoclonal antibodies [25,29] (Fig. 2F, H). However,
peptide-specific polyclonal antibodies demonstrate that
the protein is produced in all tested strains (Fig. 2E, G).
Delivery of full length and carboxy-terminal C. 
trachomatis CT223p to the host cell cytosol alters host 
cell phenotype
Plasmids encoding CT223p from several C. trachomatis
strains were transfected into both McCoy or HeLa cells
and the effect on cellular cytokinesis was observed using
fluorescent microscopy. Transfection with each of these
plasmids led to a high proportion of multinucleate cells
30 hours post transfection (Fig. 3A). A similar phenotype
was observed when cells were transfected with plasmids
encoding the carboxy-terminal tail of CT223p (Fig. 3B).
The average number of polynuclear cells following expres-
sion of a CT223  transgene was approximately 20%,
regardless of the isolate from which the gene was ampli-
fied (Figs. 4 and 5). In contrast, cells transfected with a
plasmid encoding GFP, or cells transfected with an empty
vector (mock transfected) as control, all had levels of
polynuclear cells of approximately 2–4%.
Confirmation of the polynuclear phenotype in cells infected with different C. trachomatis strains Figure 1
Confirmation of the polynuclear phenotype in cells infected with different C. trachomatis strains. Panel A: Fluo-
rescence micrograph of C. trachomatis strain LGV-434 inclusion (anti-LPS, red) within a GFP-positive cell (green), showing three 
nuclei (blue). The scale bar indicates 10 microns. Panel B: The percentage of polynuclear cells 30 h after infection of HeLa cells 
with different C. trachomatis at an MOI of 3. Strains D/UW3 and J(s)6686 are shown, along with mock-infected cells. Statistical 
significance is indicated with the asterisk above the individual treatment groups, as compared to mock-transfected cells (Stu-
dent's t-test, p < 0.001). Similar levels of significance were observed in a Kruskall-Wallis test (not shown).
* *
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The multinuclear phenotype was manifested by the car-
boxy-terminal 179 amino acids of CT223p (Fig. 4). A
reduced but still significant level of multinuclear cells
were identified in cells transfected with a plasmid encod-
ing only the carboxy-terminal 56 amino acids of CT223p,
but, transfection of a plasmid encoding an internal frag-
ment of CT223p (CT223/CT91p) did not lead to a signif-
icant level of multinuclear cells. These data suggest that
the domain of the protein responsible for blocking cyto-
kinesis was present in the carboxy-terminal 56 amino
acids.
Cytosolic expression of other incs
The orf encoding CT223p is within a likely operon encod-
ing known and candidate inc genes CT223–CT227, and is
adjacent to a very early operon containing two inc genes
(CT228 and CT229). We tested each orf in these operons
for an association with a polynuclear phenotype. Each orf
was expressed in transfected cells and there was no appar-
ent difference in expression level, based on fluorescence
microscopy of transfected cells (not shown). Orfs CT224
and CT225 also were associated with a reduced but still
statistically significant percentage of polynuclear cells in a
Expression of CT223 at different times post infection and differential reactivity with specific antibodies Figure 2
Expression of CT223 at different times post infection and differential reactivity with specific antibodies. DNA in 
all panels is labeled with DAPI (blue) and the bar in panel F represents 10 microns in each image. Cells were infected at an MOI 
of approximately 0.2 and fixed with 100% methanol prior to antibody labeling. Panels A-D: Fluorescent microscopy of McCoy 
cells infected with either strain LGV-434 (A, B) or J/UW36 (C, D). Cells were fixed at different times p.i. (A: 12 h, C: 18 h, B, 
D: 38 h). In panels A-D, cells were labeled with monoclonal anti-CT223p antibody (green) and anti-HSP60 (red). Note that 
labeling of CT223p is patchy in each strain at the early times points p.i. (A, C) but the labeling is distinct between strains at 38 
h p.i. (B, D). Panels E-H: Cells were infected with strain J/UW36 (E, F) or J(s)1980 (G, H) and fixed 30 hours p.i. Cells were 
then labeled with either polyclonal anti-CT223p antisera (E, G) or monoclonal anti-CT223p antibody (F, H), both of which are 
labeled red. Note that CT223p is labeled by the polyclonal antisera in each strain, while the monoclonal anti-CT223p does not 
label the protein in strain J(s)1980.
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Cytosolic production of CT223p and CT223/179p from C. trachomatis serovar D/UW3 leads to a multinuclear phenotype  within mammalian cells Figure 3
Cytosolic production of CT223p and CT223/179p from C. trachomatis serovar D/UW3 leads to a multinuclear 
phenotype within mammalian cells. The vector pcDNA4/HisMaxC was used in each construct. Full length CT223p (panel 
A) and CT223/179p (panel B) were produced within cells following transfection of pcDNA4-based plasmids. Each was detected 
with anti-6 × His monoclonal antibodies (red). Microtubules were detected by labeling with specific anti-tubulin antibodies 
(green). The nuclei are labeled with DAPI (blue). Panel A; McCoy cell transfected with pcDNA4/HisMaxC encoding CT223p. 
Three nuclei are localized inside of a single cell expressing CT223. Panel B; McCoy cells transfected with pcDNA4/HisMaxC 
encoding carboxy-terminal CT223/179p. The scale bar in B indicates 10 microns for each panel.
A                B
Quantification of multinuclear cells following expression of different inc genes in McCoy cells Figure 4
Quantification of multinuclear cells following expression of different inc genes in McCoy cells. This graph repre-
sents percentage of polynuclear cells among McCoy cells following transfection of pcDNA4/HisMaxC-based plasmids encoding 
different Inc proteins. Unless indicated, the sequences were derived from the published C. trachomatis D/UW3 genome 
sequence. Statistical significance is indicated with the asterisk above the individual treatment groups, as compared to pCDNA-
transfected cells (Student's t-test, p < 0.01).BMC Microbiology 2009, 9:2 http://www.biomedcentral.com/1471-2180/9/2
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transfected population (Fig. 4). None of the other tested
orfs were associated with an increased number of polynu-
clear cells.
The same approach was used for testing the effects on cell
cytokinesis of other Inc proteins. HeLa or McCoy cells
transfected with plasmids encoding each protein from C.
trachomatis incA and incC, and C. caviae incA, incB and incC
were compared with cells expressing full length and trun-
cated CT223. None of these plasmids led to an increase in
polynuclear cells relative to controls (Fig. 4).
The CT223 coding sequence from different C. trachomatis
strains encode proteins with up to 5% difference in amino
acid sequence (22). We therefore tested plasmids encod-
ing CT223p from strains with known amino acid
sequence differences for their ability to block cytokinesis.
Transfection of plasmids encoding each CT223p sequence
was associated with an increase in multinucleate cells (Fig.
5). In contrast, transfection of a plasmid expressing C.
muridarum TC0495, which is a syntenous, apparent CT223
homolog (less than 30% predicted amino acid sequence
identity), did not lead to an increase in the number of
multinucleate cells relative to controls (Fig. 5).
Cells producing CT223p and CT223/179p have increased 
numbers of centrosomes
To further explore the multinuclear phenotype, cells
expressing CT223 were labeled with antibodies specific
against γ-tubulin. In contrast to α- and β-tubulin, which
are structural components of microtubules, one of the
functions of γ-tubulin is the nucleation of microtubule
growth in all eukaryotes [30]. The microtubular organiz-
ing center, or centrosome, can therefore be identified with
antibodies to γ-tubulin. We conducted transfection exper-
iments with plasmids encoding both full length CT223p
and the truncated CT223/179p molecule, and these cells
also had statistically significant increases in the number of
centrosomes, relative to control transfections (Fig. 6).
These results are consistent with those of Grieshaber et al.
[14], who demonstrated that there are centrosomal supra-
numeracy defects in C. trachomatis-infected cells.
Discussion
CT223p is a chlamydial Inc protein that varies antigeni-
cally but is produced by all tested C. trachomatis isolates.
The protein was detected in our analysis at 8 h p.i. (not
shown) and was abundant on the inclusion membrane at
all subsequent time points. This is consistent with the
transcriptional profiling of Belland et al. [26], who dem-
onstrate that the transcript for CT223 is first detected 8 h
p.i. and remains actively transcribed for the rest of the
developmental cycle. The gene is clustered with a set of
orfs (CT223–CT229) encoding known or candidate inclu-
sion membrane proteins that are only found in the C. tra-
chomatis  and  C. muridarum genomes [24]. CT223p is
localized as patches or short ribbon-like distribution in all
strains examined prior to 30 h p.i. At later time points the
Quantification of multinuclear cells following expression in McCoy cells of CT223 alleles from different C. trachomatis strains Figure 5
Quantification of multinuclear cells following expression in McCoy cells of CT223 alleles from different C. tra-
chomatis strains. Statistical significance is indicated with the asterisk above the individual treatment groups, as compared to 
pcDNA-transfected cells (Student's t-test, p < 0.01).BMC Microbiology 2009, 9:2 http://www.biomedcentral.com/1471-2180/9/2
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protein is differently distributed in different strains,
shown in this work in a comparison between a serovar J
strain and a serovar L2 strain. Tested isolates of serovar D
appear similarly to the serovar L2 strain (not shown).
The ability of C. trachomatis to affect the mammalian cell
cycle has been documented by several authors. Greene
and Zhong [13] established that infection by C. trachoma-
tis affects host cell cytokinesis in a multiplicity of infec-
tion-dependent manner, results that were confirmed in
our work (Fig. 1). Grieshaber et al. [14] demonstrated that
chlamydial inclusions associate with the centrosome lead-
ing to increased numbers of centrosomes and chromo-
some segregation defects in infected cells. Molecular
interactions between chlamydiae and host molecules
important in cell division were explored by Balsara et al.
[15] who showed that chlamydial infection leads to alter-
ations in the abundance of cyclin-dependent kinases and
to the cleavage of cyclin B1. However, any chlamydial pro-
teins that might participate in the alteration of the host
cell cycle have not been identified.
While it is possible that the observed multinuclear pheno-
type is a function of cellular fusion, as opposed to inhibi-
tion of cytokinesis, Greene and Zhong [13] discuss several
lines of evidence that point to the latter possibility. This
includes the lack of observed fusion intermediates, the
presence of mitotic forms, and normal DNA synthesis in
chlamydiae-infected host cells. These observations sup-
port the likelihood that cells are being blocked in a termi-
nal state of division, as opposed to being stimulated to
fusion with neighboring cells, following chlamydial infec-
tion.
CT223p was first examined as a candidate Inc protein
because of the presence of an amino-terminal bi-lobed
hydrophobic domain that is proposed to be a membrane
anchor for Incs [25]. Like many Incs, CT223p also con-
Centrosome supranumeracy in cells transfected with plasmids encoding C. trachomatis serovar D CT223p and CT223/179p Figure 6
Centrosome supranumeracy in cells transfected with plasmids encoding C. trachomatis serovar D CT223p and 
CT223/179p. The vector pcDNA4/HisMaxC was used in each construct. The proteins CT223p and CT223/179p were 
detected with anti-6 × His monoclonal antibody and are labeled in red. Structures of γ-tubulin were detected by labeling with 
anti γ-tubulin antibodies and are stained in green. The nuclei are labeled with DAPI (blue). Panel A; McCoy cell transfected with 
pcDNA4/HisMaxC encoding CT223p. Three nuclei are localized inside of a single cell expressing CT223. Multiple centrosomes 
are shown with an arrow. The scale bar indicates 10 microns. Panel B; The percentage of cells with multiple centrosomes 
among cells transfected with plasmids encoding CT223p or CT223/179p (CT223c), or cells transfected with the pcDNA4/His-
MaxC vector only (Mock). The vertical axis indicates the percent of cells that had two or more centrosomes. At least 500 cells 
were tested for each construct. The proportions of cells containing 2 or more centrosomes were significantly different than 
the mock-transfected cells for both the full length and truncated CT223 sequences. Statistical significance is indicated with the 
asterisk above the individual treatment groups, as compared to mock-transfected cells (Student's t-test, p < 0.001).
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tains a long carboxy-terminal tail that is largely
hydrophilic. It is likely that this carboxy-terminal region
of the protein is responsible for direct interactions
between Incs and proteins in the host cell cytosol, a prop-
erty shown to be true for tested Inc proteins [7,21,22].
Transfection of cells with plasmids encoding only the car-
boxy-terminal 179 amino acids or (to a lesser extent) the
56 carboxy-terminal amino acids of CT223p led to
increased accumulation of host cell nuclei within cells.
We have sequence data for CT223p from several C. tracho-
matis  isolates and, while there is sequence variation
among strains, the carboxy-terminal third of the protein is
highly conserved [[29]; data not shown].
Two other Inc proteins, CT224p and CT225p, also
affected host cell cytokinesis, although the effect was less
than that observed with CT223p. These proteins are
encoded sequentially in the C. trachomatis genome and are
unique to this species. However, the predicted protein
sequences of these three proteins share very limited pri-
mary amino acid identity. In contrast, the protein product
of C. muridarum orf  TC0495, an apparent homolog of
CT223 that is encoded in a syntenous operon [29] did not
block cytokinesis in our assays. The degree of identity
between CT223p and TC0495p is not high, and it is likely
that key structures between the two proteins are not con-
served in a way that allows the C. muridarum protein to
affect cytokinesis in this assay. The degree of identity
among CT223p, CT224p and CT225p is even lower, and,
therefore, it is even less intuitive that these proteins would
share a common phenotype when produced within mam-
malian cells. Therefore, the molecular mechanisms associ-
ated with the inhibition of cytokinesis observed in these
studies remain unclear.
There are many possible steps in the complicated process
of cell division that might be affected by the Incs that
affect cytokinesis. The cell cycle is under control of a fam-
ily of protein kinases known as Cyclin-dependent kinases
(Cdks), which are under control of various regulatory pro-
teins such as CAK and CKIs [31,32]. Some of these pro-
teins are differently processed or differently abundant in
chlamydiae-infected vs. uninfected cultured cells [15]. We
hypothesize that CT223p and other Inc proteins directly
or indirectly disrupt Cdk, cyclin, or possibly other protein
functions and, thus, affect cell cycle control. We are cur-
rently using surrogate systems to identify possible host
cell cycle-specific proteins that interact directly with
CT223p at the inclusion membrane surface.
Conclusion
Plasmid-based expression of the chlamydial inclusion
membrane protein CT223p caused a reduction in mam-
malian cell cytokinesis in vitro. Other Inc proteins had a
lesser effect on cytokinesis in this assay. These results sup-
port the conclusion that Ct223 expression by C. trachoma-
tis  and localization of the protein to the inclusion
membrane is associated with the observed inhibition of
host cell cytokinesis in C. trachomatis-infected host cells.
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